author_facet Quarta, Candida Cristina
Gonzalez-Lopez, Esther
Gilbertson, Janet A.
Botcher, Nichola
Rowczenio, Dorota
Petrie, Aviva
Rezk, Tamer
Youngstein, Taryn
Mahmood, Shameem
Sachchithanantham, Sajitha
Lachmann, Helen J.
Fontana, Marianna
Whelan, Carol J.
Wechalekar, Ashutosh D.
Hawkins, Philip N.
Gillmore, Julian D.
Quarta, Candida Cristina
Gonzalez-Lopez, Esther
Gilbertson, Janet A.
Botcher, Nichola
Rowczenio, Dorota
Petrie, Aviva
Rezk, Tamer
Youngstein, Taryn
Mahmood, Shameem
Sachchithanantham, Sajitha
Lachmann, Helen J.
Fontana, Marianna
Whelan, Carol J.
Wechalekar, Ashutosh D.
Hawkins, Philip N.
Gillmore, Julian D.
author Quarta, Candida Cristina
Gonzalez-Lopez, Esther
Gilbertson, Janet A.
Botcher, Nichola
Rowczenio, Dorota
Petrie, Aviva
Rezk, Tamer
Youngstein, Taryn
Mahmood, Shameem
Sachchithanantham, Sajitha
Lachmann, Helen J.
Fontana, Marianna
Whelan, Carol J.
Wechalekar, Ashutosh D.
Hawkins, Philip N.
Gillmore, Julian D.
spellingShingle Quarta, Candida Cristina
Gonzalez-Lopez, Esther
Gilbertson, Janet A.
Botcher, Nichola
Rowczenio, Dorota
Petrie, Aviva
Rezk, Tamer
Youngstein, Taryn
Mahmood, Shameem
Sachchithanantham, Sajitha
Lachmann, Helen J.
Fontana, Marianna
Whelan, Carol J.
Wechalekar, Ashutosh D.
Hawkins, Philip N.
Gillmore, Julian D.
European Heart Journal
Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
Cardiology and Cardiovascular Medicine
author_sort quarta, candida cristina
spelling Quarta, Candida Cristina Gonzalez-Lopez, Esther Gilbertson, Janet A. Botcher, Nichola Rowczenio, Dorota Petrie, Aviva Rezk, Tamer Youngstein, Taryn Mahmood, Shameem Sachchithanantham, Sajitha Lachmann, Helen J. Fontana, Marianna Whelan, Carol J. Wechalekar, Ashutosh D. Hawkins, Philip N. Gillmore, Julian D. 0195-668X 1522-9645 Oxford University Press (OUP) Cardiology and Cardiovascular Medicine http://dx.doi.org/10.1093/eurheartj/ehx047 <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Aims</jats:title> <jats:p>Congo red staining of an endomyocardial biopsy is the diagnostic gold-standard in suspected cardiac amyloidosis (CA), but the procedure is associated with the risk, albeit small, of serious complications, and delay in diagnosis due to the requirement for technical expertise. In contrast, abdominal fat pad fine needle aspiration (FPFNA) is a simple, safe and well-established procedure in systemic amyloidosis, but its diagnostic sensitivity in patients with suspected CA remains unclear.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods and results</jats:title> <jats:p>We assessed the diagnostic sensitivity of FPFNA in 600 consecutive patients diagnosed with CA [216 AL amyloidosis, 113 hereditary transthyretin (ATTRm), and 271 wild-type transthyretin (ATTRwt) amyloidosis] at our Centre. Amyloid was detected on Congo red staining of FPFNAs in 181/216 (84%) patients with cardiac AL amyloidosis, including 100, 97, and 78% of those with a large, moderate, and small whole-body amyloid burden, respectively, as assessed by serum amyloid P (SAP) component scintigraphy (P &amp;lt; 0.001); the deposits were successfully typed as AL by immunohistochemistry in 102/216 (47%) cases. Amyloid was detected in FPFNAs of 51/113 (45%) patients with ATTRm CA, and only 42/271 (15%) cases with ATTRwt CA.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>FPFNA has reasonable diagnostic sensitivity in cardiac AL amyloidosis, particularly in patients with a large whole-body amyloid burden. Although the diagnostic sensitivity of FPFNA is substantially lower in transthyretin CA, particularly ATTRwt, it may nevertheless sometimes obviate the need for endomyocardial biopsy.</jats:p> </jats:sec> Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis European Heart Journal
doi_str_mv 10.1093/eurheartj/ehx047
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9ldXJoZWFydGovZWh4MDQ3
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9ldXJoZWFydGovZWh4MDQ3
institution DE-Gla1
DE-Zi4
DE-15
DE-Rs1
DE-Pl11
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint Oxford University Press (OUP), 2017
imprint_str_mv Oxford University Press (OUP), 2017
issn 0195-668X
1522-9645
issn_str_mv 0195-668X
1522-9645
language English
mega_collection Oxford University Press (OUP) (CrossRef)
match_str quarta2017diagnosticsensitivityofabdominalfataspirationincardiacamyloidosis
publishDateSort 2017
publisher Oxford University Press (OUP)
recordtype ai
record_format ai
series European Heart Journal
source_id 49
title Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
title_unstemmed Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
title_full Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
title_fullStr Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
title_full_unstemmed Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
title_short Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
title_sort diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
topic Cardiology and Cardiovascular Medicine
url http://dx.doi.org/10.1093/eurheartj/ehx047
publishDate 2017
physical 1905-1908
description <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Aims</jats:title> <jats:p>Congo red staining of an endomyocardial biopsy is the diagnostic gold-standard in suspected cardiac amyloidosis (CA), but the procedure is associated with the risk, albeit small, of serious complications, and delay in diagnosis due to the requirement for technical expertise. In contrast, abdominal fat pad fine needle aspiration (FPFNA) is a simple, safe and well-established procedure in systemic amyloidosis, but its diagnostic sensitivity in patients with suspected CA remains unclear.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods and results</jats:title> <jats:p>We assessed the diagnostic sensitivity of FPFNA in 600 consecutive patients diagnosed with CA [216 AL amyloidosis, 113 hereditary transthyretin (ATTRm), and 271 wild-type transthyretin (ATTRwt) amyloidosis] at our Centre. Amyloid was detected on Congo red staining of FPFNAs in 181/216 (84%) patients with cardiac AL amyloidosis, including 100, 97, and 78% of those with a large, moderate, and small whole-body amyloid burden, respectively, as assessed by serum amyloid P (SAP) component scintigraphy (P &amp;lt; 0.001); the deposits were successfully typed as AL by immunohistochemistry in 102/216 (47%) cases. Amyloid was detected in FPFNAs of 51/113 (45%) patients with ATTRm CA, and only 42/271 (15%) cases with ATTRwt CA.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>FPFNA has reasonable diagnostic sensitivity in cardiac AL amyloidosis, particularly in patients with a large whole-body amyloid burden. Although the diagnostic sensitivity of FPFNA is substantially lower in transthyretin CA, particularly ATTRwt, it may nevertheless sometimes obviate the need for endomyocardial biopsy.</jats:p> </jats:sec>
container_issue 24
container_start_page 1905
container_title European Heart Journal
container_volume 38
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792345803859165188
geogr_code not assigned
last_indexed 2024-03-01T17:29:17.398Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Diagnostic+sensitivity+of+abdominal+fat+aspiration+in+cardiac+amyloidosis&rft.date=2017-06-21&genre=article&issn=1522-9645&volume=38&issue=24&spage=1905&epage=1908&pages=1905-1908&jtitle=European+Heart+Journal&atitle=Diagnostic+sensitivity+of+abdominal+fat+aspiration+in+cardiac+amyloidosis&aulast=Gillmore&aufirst=Julian+D.&rft_id=info%3Adoi%2F10.1093%2Feurheartj%2Fehx047&rft.language%5B0%5D=eng
SOLR
_version_ 1792345803859165188
author Quarta, Candida Cristina, Gonzalez-Lopez, Esther, Gilbertson, Janet A., Botcher, Nichola, Rowczenio, Dorota, Petrie, Aviva, Rezk, Tamer, Youngstein, Taryn, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Fontana, Marianna, Whelan, Carol J., Wechalekar, Ashutosh D., Hawkins, Philip N., Gillmore, Julian D.
author_facet Quarta, Candida Cristina, Gonzalez-Lopez, Esther, Gilbertson, Janet A., Botcher, Nichola, Rowczenio, Dorota, Petrie, Aviva, Rezk, Tamer, Youngstein, Taryn, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Fontana, Marianna, Whelan, Carol J., Wechalekar, Ashutosh D., Hawkins, Philip N., Gillmore, Julian D., Quarta, Candida Cristina, Gonzalez-Lopez, Esther, Gilbertson, Janet A., Botcher, Nichola, Rowczenio, Dorota, Petrie, Aviva, Rezk, Tamer, Youngstein, Taryn, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Fontana, Marianna, Whelan, Carol J., Wechalekar, Ashutosh D., Hawkins, Philip N., Gillmore, Julian D.
author_sort quarta, candida cristina
container_issue 24
container_start_page 1905
container_title European Heart Journal
container_volume 38
description <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Aims</jats:title> <jats:p>Congo red staining of an endomyocardial biopsy is the diagnostic gold-standard in suspected cardiac amyloidosis (CA), but the procedure is associated with the risk, albeit small, of serious complications, and delay in diagnosis due to the requirement for technical expertise. In contrast, abdominal fat pad fine needle aspiration (FPFNA) is a simple, safe and well-established procedure in systemic amyloidosis, but its diagnostic sensitivity in patients with suspected CA remains unclear.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods and results</jats:title> <jats:p>We assessed the diagnostic sensitivity of FPFNA in 600 consecutive patients diagnosed with CA [216 AL amyloidosis, 113 hereditary transthyretin (ATTRm), and 271 wild-type transthyretin (ATTRwt) amyloidosis] at our Centre. Amyloid was detected on Congo red staining of FPFNAs in 181/216 (84%) patients with cardiac AL amyloidosis, including 100, 97, and 78% of those with a large, moderate, and small whole-body amyloid burden, respectively, as assessed by serum amyloid P (SAP) component scintigraphy (P &amp;lt; 0.001); the deposits were successfully typed as AL by immunohistochemistry in 102/216 (47%) cases. Amyloid was detected in FPFNAs of 51/113 (45%) patients with ATTRm CA, and only 42/271 (15%) cases with ATTRwt CA.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>FPFNA has reasonable diagnostic sensitivity in cardiac AL amyloidosis, particularly in patients with a large whole-body amyloid burden. Although the diagnostic sensitivity of FPFNA is substantially lower in transthyretin CA, particularly ATTRwt, it may nevertheless sometimes obviate the need for endomyocardial biopsy.</jats:p> </jats:sec>
doi_str_mv 10.1093/eurheartj/ehx047
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9ldXJoZWFydGovZWh4MDQ3
imprint Oxford University Press (OUP), 2017
imprint_str_mv Oxford University Press (OUP), 2017
institution DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 0195-668X, 1522-9645
issn_str_mv 0195-668X, 1522-9645
language English
last_indexed 2024-03-01T17:29:17.398Z
match_str quarta2017diagnosticsensitivityofabdominalfataspirationincardiacamyloidosis
mega_collection Oxford University Press (OUP) (CrossRef)
physical 1905-1908
publishDate 2017
publishDateSort 2017
publisher Oxford University Press (OUP)
record_format ai
recordtype ai
series European Heart Journal
source_id 49
spelling Quarta, Candida Cristina Gonzalez-Lopez, Esther Gilbertson, Janet A. Botcher, Nichola Rowczenio, Dorota Petrie, Aviva Rezk, Tamer Youngstein, Taryn Mahmood, Shameem Sachchithanantham, Sajitha Lachmann, Helen J. Fontana, Marianna Whelan, Carol J. Wechalekar, Ashutosh D. Hawkins, Philip N. Gillmore, Julian D. 0195-668X 1522-9645 Oxford University Press (OUP) Cardiology and Cardiovascular Medicine http://dx.doi.org/10.1093/eurheartj/ehx047 <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Aims</jats:title> <jats:p>Congo red staining of an endomyocardial biopsy is the diagnostic gold-standard in suspected cardiac amyloidosis (CA), but the procedure is associated with the risk, albeit small, of serious complications, and delay in diagnosis due to the requirement for technical expertise. In contrast, abdominal fat pad fine needle aspiration (FPFNA) is a simple, safe and well-established procedure in systemic amyloidosis, but its diagnostic sensitivity in patients with suspected CA remains unclear.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods and results</jats:title> <jats:p>We assessed the diagnostic sensitivity of FPFNA in 600 consecutive patients diagnosed with CA [216 AL amyloidosis, 113 hereditary transthyretin (ATTRm), and 271 wild-type transthyretin (ATTRwt) amyloidosis] at our Centre. Amyloid was detected on Congo red staining of FPFNAs in 181/216 (84%) patients with cardiac AL amyloidosis, including 100, 97, and 78% of those with a large, moderate, and small whole-body amyloid burden, respectively, as assessed by serum amyloid P (SAP) component scintigraphy (P &amp;lt; 0.001); the deposits were successfully typed as AL by immunohistochemistry in 102/216 (47%) cases. Amyloid was detected in FPFNAs of 51/113 (45%) patients with ATTRm CA, and only 42/271 (15%) cases with ATTRwt CA.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>FPFNA has reasonable diagnostic sensitivity in cardiac AL amyloidosis, particularly in patients with a large whole-body amyloid burden. Although the diagnostic sensitivity of FPFNA is substantially lower in transthyretin CA, particularly ATTRwt, it may nevertheless sometimes obviate the need for endomyocardial biopsy.</jats:p> </jats:sec> Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis European Heart Journal
spellingShingle Quarta, Candida Cristina, Gonzalez-Lopez, Esther, Gilbertson, Janet A., Botcher, Nichola, Rowczenio, Dorota, Petrie, Aviva, Rezk, Tamer, Youngstein, Taryn, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Fontana, Marianna, Whelan, Carol J., Wechalekar, Ashutosh D., Hawkins, Philip N., Gillmore, Julian D., European Heart Journal, Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis, Cardiology and Cardiovascular Medicine
title Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
title_full Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
title_fullStr Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
title_full_unstemmed Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
title_short Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
title_sort diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
title_unstemmed Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
topic Cardiology and Cardiovascular Medicine
url http://dx.doi.org/10.1093/eurheartj/ehx047